Predicting Products: SN1 vs. SN2
Mutations
Mutations
Viral Mutations
PD Controller: Design
Predicting Molecular Geometry
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 15, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Objective response rates to anti-PD-1 therapies correlate with tumor mutation burden across many cancer types. Some cancers, like Merkel cell carcinoma, show higher response rates, while others, like proficient colorectal cancer, show lower rates.
Area of Science:
Background: